ATE204018T1 - Zellwachstumsinhibitoren - Google Patents

Zellwachstumsinhibitoren

Info

Publication number
ATE204018T1
ATE204018T1 AT91918746T AT91918746T ATE204018T1 AT E204018 T1 ATE204018 T1 AT E204018T1 AT 91918746 T AT91918746 T AT 91918746T AT 91918746 T AT91918746 T AT 91918746T AT E204018 T1 ATE204018 T1 AT E204018T1
Authority
AT
Austria
Prior art keywords
pct
gbp
cell growth
sec
show
Prior art date
Application number
AT91918746T
Other languages
English (en)
Inventor
Livio Mallucci
Valerie Wells
Original Assignee
Livio Mallucci
Valerie Wells
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Livio Mallucci, Valerie Wells filed Critical Livio Mallucci
Application granted granted Critical
Publication of ATE204018T1 publication Critical patent/ATE204018T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91918746T 1990-11-02 1991-10-30 Zellwachstumsinhibitoren ATE204018T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023907A GB9023907D0 (en) 1990-11-02 1990-11-02 Cell growth inhibitors
PCT/GB1991/001898 WO1992007938A1 (en) 1990-11-02 1991-10-30 Cell growth inhibitors

Publications (1)

Publication Number Publication Date
ATE204018T1 true ATE204018T1 (de) 2001-08-15

Family

ID=10684796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918746T ATE204018T1 (de) 1990-11-02 1991-10-30 Zellwachstumsinhibitoren

Country Status (11)

Country Link
US (1) US6127169A (de)
EP (1) EP0555286B1 (de)
JP (1) JP3497504B2 (de)
AT (1) ATE204018T1 (de)
AU (1) AU650066B2 (de)
CA (1) CA2095335C (de)
DE (1) DE69132682T2 (de)
GB (2) GB9023907D0 (de)
IE (1) IE913816A1 (de)
IL (1) IL99940A0 (de)
WO (1) WO1992007938A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
WO1993022449A1 (en) * 1992-04-27 1993-11-11 Kansas State University Research Foundation Inhibitory factor
AU9301998A (en) * 1997-09-05 1999-03-22 Board Of Regents Of The University Of Oklahoma, The Composition and methods using galectin-1
US5948628A (en) 1997-09-05 1999-09-07 The Board Of Regents Of The University Of Oklahoma Methods of screening for compounds which mimic galectin-1
JP2002322082A (ja) * 2001-04-26 2002-11-08 Purotejiin:Kk 腎炎の予防・治療剤
US7994113B2 (en) 2007-06-14 2011-08-09 Livio Mallucci βGBP, compositions comprising βGBP, and related methods and uses thereof
GB2450146A (en) * 2007-06-14 2008-12-17 Livio Mallucci ßGBP, compositions comprising ßGBP, and related methods and uses thereof
WO2008152078A1 (de) * 2007-06-15 2008-12-18 Basf Se Voc-arme wässrige hybridbindemittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63164895A (ja) * 1986-09-13 1988-07-08 Sanwa Kagaku Kenkyusho Co Ltd 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
EP0375736B1 (de) * 1987-08-20 1998-05-13 Children's Medical Center Corporation Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
DE68926916T2 (de) * 1988-04-14 1997-01-30 Incyte Pharma Inc 14-Beta-gal Sauger-Lectin

Also Published As

Publication number Publication date
US6127169A (en) 2000-10-03
EP0555286B1 (de) 2001-08-08
CA2095335C (en) 2002-10-22
IL99940A0 (en) 1992-08-18
IE913816A1 (en) 1992-05-22
DE69132682T2 (de) 2002-07-04
DE69132682D1 (de) 2001-09-13
GB9023907D0 (en) 1990-12-12
WO1992007938A1 (en) 1992-05-14
GB9123036D0 (en) 1991-12-18
CA2095335A1 (en) 1992-05-03
AU8756591A (en) 1992-05-26
JP3497504B2 (ja) 2004-02-16
AU650066B2 (en) 1994-06-09
JPH06502302A (ja) 1994-03-17
EP0555286A1 (de) 1993-08-18
GB2249312A (en) 1992-05-06
GB2249312B (en) 1994-11-16

Similar Documents

Publication Publication Date Title
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
HUP0104717A2 (hu) Készítmények és eljárások petefészekrák terápiájára és diagnózisára
BR0206985A (pt) Anticorpos modificados e métodos de uso
ATE189527T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
DE69131699D1 (de) Verändertes menschliches iL-6
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
IL118167A0 (en) Pyrazolo (1,5a) pyrimidines their preparation and use
DK0837935T3 (da) Den 3'-ikke-translaterede region af det humane prohibitin-gen
DE69132682D1 (de) Zellwachstumsinhibitoren
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
FI942442A0 (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
SE9402880D0 (sv) New peptide derivatives
NO980005L (no) Terapautiske midler og autoimmunsykdommer
DK0783307T3 (da) Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2071343T3 (es) Nuevos peptidos con actividad anticoagulatoria.
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DK0580782T3 (da) Anti-HIV-protein, TAP 29, fra Trichosanthes, DNA, som koder derfor, og terapeutiske anvendelser deraf
IT1299201B1 (it) Fibroblasti modificati geneticamente e loro uso
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
UA23310A (uk) Спосіб лікуваhhя ішемічhої хвороби серця з супровідhою патологією гєпатобіліарhої системи
Lgvignac General Announcements

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties